Average Co-Inventor Count = 4.15
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Glaxosmithkline LLC (8 from 356 patents)
2. Smithkline Beecham Corporation (6 from 2,198 patents)
3. Glaxosmithkline Intellectual Property (No.2) Limited (3 from 95 patents)
4. Other (1 from 832,880 patents)
5. Nps Pharmaceuticals, Inc. (1 from 93 patents)
18 patents:
1. 10478426 - Enhancer of Zeste Homolog 2 inhibitors
2. 9956210 - Enhancer of zeste homolog 2 inhibitors
3. 9790212 - Enhancer of zeste homolog 2 inhibitors
4. 9562041 - Enhancer of zeste homolog 2 inhibitors
5. 9556157 - Enhancer of zeste homolog 2 inhibitors
6. 9505745 - Enhancer of zeste homolog 2 inhibitors
7. 9402836 - Indoles
8. 9073924 - Azaindazoles
9. 8975291 - Indoles
10. 8637509 - Azaindazoles
11. 8404837 - Quinoline derivatives as P13 kinase inhibitors
12. 7482455 - Chemical compounds
13. 7166639 - NF-κB inhibitors
14. 7109238 - Calcilytic compounds
15. 7087758 - Quinoline inhibitors of hyaki and hyak3 kinases